Contact US

Weight Loss Plateau with Ozempic

Did you know that plateaus are a natural part of the weight loss journey? I know what you’re asking – WHY!!?!

After just one week, many people say they’re in a plateau. But a plateau can last for weeks! I’m not providing much optimism for you right now, am I? Sorry, not sorry… 

The ebb and flow of weight loss can be an absolute gong show of emotions, but consistency is key. 

Let’s get into it.

 

–

Related weight loss medication videos: 

▪️ Ozempic Paralyzed My Stomach: https://youtu.be/tj9thkkN5aM 

▪️ Live Wednesday: Breaking Through a Weight Loss Plateau with Ozempic: https://www.youtube.com/live/PSp3Nnn8J-Y 

▪️ Canadian Ozempic Shortage: https://youtu.be/0QhnCMr-2dY

—

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link – https://healthevolved.co/ozempic-plateau

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

The Ozempic Pill Has a Ceiling — New Trial Proves It

New clinical trial data on orforglipron reveals a biological ceiling that every person on GLP-1 medications needs to understand. I’m breaking down the ATTAIN-MAINTAIN trial findings, explaining what the 15% threshold means for long-term weight management, and identifying exactly who is — and isn’t — a strong candidate for the transition to the Ozempic pill.

Reducing Your Zebound Dose Could Undo ALL Your Progress

The SURMOUNT MAINTAIN trial has delivered the most compelling evidence yet that obesity requires long-term management — not a finish line. New data reveals exactly what happens to your results at every dose decision, and the numbers make the choice undeniable.

The Retatrutide Paradox: Why This “Triple Threat” Works

Retatrutide is a triple-action therapy targeting GLP-1, GIP, and glucagon receptors simultaneously — a fundamentally different design from current treatments. Early clinical data reveals significant liver-fat reductions and an unexpected paradox: a receptor long assumed to raise blood sugar instead helps mobilize stored fat and support resting metabolism.

Retatrutide TRIUMPH-1 Results: 28% Weight Loss

TRIUMPH-1 Phase 3 trial data reveals retatrutide achieved up to 30% body weight loss — outperforming bariatric surgery benchmarks without a single incision. I’m breaking down the full efficacy numbers, safety signals, and what this triple-hormone agonist means for your weight management options right now.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Get Started

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Get Started